165 related articles for article (PubMed ID: 32088189)
21. Overexpression of B7-H4 is associated with infiltrating immune cells and poor prognosis in metastatic colorectal cancer.
Ding S; Lv X; Liu Z; Zhan S; Xu Y; Zhang X; Liu C; Cao L
Int Immunopharmacol; 2021 Jan; 90():107144. PubMed ID: 33187907
[TBL] [Abstract][Full Text] [Related]
22. Prognostic role of B7-H4 in patients with non-small cell lung cancer: A meta-analysis.
Tan Z; Shen W
Oncotarget; 2017 Apr; 8(16):27137-27144. PubMed ID: 28404927
[TBL] [Abstract][Full Text] [Related]
23. [Expression of B7-H4 in prostate cancer and its clinical significance].
Qian Y; Yao HP; Shen L; Cheng LF; Zhang LH
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2010 Jul; 39(4):345-9. PubMed ID: 20731031
[TBL] [Abstract][Full Text] [Related]
24. LETM1 is a potential biomarker that predicts poor prognosis in gastric adenocarcinoma.
Li H; Piao L; Xu D; Xuan Y
Exp Mol Pathol; 2020 Feb; 112():104333. PubMed ID: 31705880
[TBL] [Abstract][Full Text] [Related]
25. The inhibitory role of b7-h4 in antitumor immunity: association with cancer progression and survival.
He C; Qiao H; Jiang H; Sun X
Clin Dev Immunol; 2011; 2011():695834. PubMed ID: 22013483
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of soluble H7-B4 in pleural effusion associated with lung cancer.
Xu CH; Cao L; Zhang XW; Yan J; Yu LK
Tumour Biol; 2015 Jun; 36(6):4397-403. PubMed ID: 25636447
[TBL] [Abstract][Full Text] [Related]
27. Ablation of B7-H3 but Not B7-H4 Results in Highly Increased Tumor Burden in a Murine Model of Spontaneous Prostate Cancer.
Kreymborg K; Haak S; Murali R; Wei J; Waitz R; Gasteiger G; Savage PA; van den Brink MR; Allison JP
Cancer Immunol Res; 2015 Aug; 3(8):849-54. PubMed ID: 26122284
[TBL] [Abstract][Full Text] [Related]
28. Expression of costimulatory molecules B7-H1, B7-H4 and Foxp3+ Tregs in gastric cancer and its clinical significance.
Geng Y; Wang H; Lu C; Li Q; Xu B; Jiang J; Wu C
Int J Clin Oncol; 2015 Apr; 20(2):273-81. PubMed ID: 24804867
[TBL] [Abstract][Full Text] [Related]
29. Down-regulation of protein kinase, DNA-activated, catalytic polypeptide attenuates tumor progression and is an independent prognostic predictor of survival in prostate cancer.
Zhang X; Wang Y; Ning Y
Urol Oncol; 2017 Mar; 35(3):111.e15-111.e23. PubMed ID: 27856181
[TBL] [Abstract][Full Text] [Related]
30. B7-H3 and B7-H4 expression in phyllodes tumors of the breast detected by RNA in situ hybridization and immunohistochemistry: Association with clinicopathological features and T-cell infiltration.
Kim GE; Kim NI; Park MH; Lee JS
Tumour Biol; 2018 Nov; 40(11):1010428318815032. PubMed ID: 30486739
[TBL] [Abstract][Full Text] [Related]
31. Does B7-H4 expression correlate with clinicopathologic characteristics and survival in ovarian cancer?: A systematic review and PRISMA-compliant meta-analysis.
Ye Y; Wang JJ; Li SL; Wang SY; Jing FH
Medicine (Baltimore); 2018 Aug; 97(32):e11821. PubMed ID: 30095655
[TBL] [Abstract][Full Text] [Related]
32. Negative roles of B7-H3 and B7-H4 in the microenvironment of cervical cancer.
Han S; Wang Y; Shi X; Zong L; Liu L; Zhang J; Qian Q; Jin J; Ma Y; Cui B; Yang X; Kong B; Zhang Y
Exp Cell Res; 2018 Oct; 371(1):222-230. PubMed ID: 30099052
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA Expression Profiling of Pancreatic Cancer Cell Line L3.6p1 Following B7-H4 Knockdown.
Qian Y; Feng L; Wu W; Weng T; Hu C; Hong B; Wang FXC; Shen L; Wang Q; Jin X; Yao H
Cell Physiol Biochem; 2017; 44(2):494-504. PubMed ID: 29145206
[TBL] [Abstract][Full Text] [Related]
34. B7-H3 and B7-H4 Expression in Breast Cancer and Their Association with Clinicopathological Variables and T Cell Infiltration.
Kim NI; Park MH; Kweon SS; Lee JS
Pathobiology; 2020; 87(3):179-192. PubMed ID: 32088722
[TBL] [Abstract][Full Text] [Related]
35. Combined detection of CA19-9 and B7-H4 in the diagnosis and prognosis of pancreatic cancer.
Xu X; Xiao Y; Hong B; Hao B; Qian Y
Cancer Biomark; 2019; 25(3):251-257. PubMed ID: 31282407
[TBL] [Abstract][Full Text] [Related]
36. B7-H3, B7-H4, Foxp3 and IL-2 expression in cervical cancer: Associations with patient outcome and clinical significance.
Huang C; Zhou L; Chang X; Pang X; Zhang H; Zhang S
Oncol Rep; 2016 Apr; 35(4):2183-90. PubMed ID: 26848032
[TBL] [Abstract][Full Text] [Related]
37. Impact of neoadjuvant chemotherapy on lymphocytes and co-inhibitory B7-H4 molecule in gastric cancer: low B7-H4 expression associates with favorable prognosis.
Maskey N; Li K; Hu M; Xu Z; Peng C; Yu F; Cao H; Chen J; Li Y; Yang G
Tumour Biol; 2014 Dec; 35(12):11837-43. PubMed ID: 25260881
[TBL] [Abstract][Full Text] [Related]
38. Granulocyte-Macrophage Colony-Stimulating Factor-Activated Neutrophils Express B7-H4 That Correlates with Gastric Cancer Progression and Poor Patient Survival.
Shan ZG; Yan ZB; Peng LS; Cheng P; Teng YS; Mao FY; Fan K; Zhuang Y; Zhao YL
J Immunol Res; 2021; 2021():6613247. PubMed ID: 33763491
[TBL] [Abstract][Full Text] [Related]
39. B7-H1 and B7-H4 expression in colorectal carcinoma: correlation with tumor FOXP3(+) regulatory T-cell infiltration.
Zhao LW; Li C; Zhang RL; Xue HG; Zhang FX; Zhang F; Gai XD
Acta Histochem; 2014 Sep; 116(7):1163-8. PubMed ID: 25053455
[TBL] [Abstract][Full Text] [Related]
40. RCD24, B7-H4 and PCNA expression and clinical significance in ovarian cancer.
Zheng C; Yang R
J BUON; 2019; 24(2):715-719. PubMed ID: 31128028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
